Thursday, June 19, 2014 10:33:04 AM
From the decision: "...the relevant question is whether the claims here do more than simply instruct the practitioner to implement the abstract idea of intermediated settlement on a generic computer...."
So for DSS, I believe the patents are much more advanced and the inventions are not limited to an abstract idea that can simply be implemented via computer. The patents are specific to computer objects and the linking/connecting of such objects. These concepts do not exist in the non-computer world. As such, the SCOTUS decision does not limit or pose an invalidation threat to Bascom/DSS inventions.
But still waiting for a market reaction.
So for DSS, I believe the patents are much more advanced and the inventions are not limited to an abstract idea that can simply be implemented via computer. The patents are specific to computer objects and the linking/connecting of such objects. These concepts do not exist in the non-computer world. As such, the SCOTUS decision does not limit or pose an invalidation threat to Bascom/DSS inventions.
But still waiting for a market reaction.
Recent DSS News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/17/2026 08:53:21 PM
- DSS, Inc. Letter to Shareholders • GlobeNewswire Inc. • 04/15/2026 08:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 09:00:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:30:59 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 02/17/2026 09:30:13 PM
- Form PRER14C - Information statements • Edgar (US Regulatory) • 02/06/2026 08:19:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 10:06:08 PM
- DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering • GlobeNewswire Inc. • 02/05/2026 02:45:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/05/2026 12:46:51 PM
- DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering • GlobeNewswire Inc. • 02/04/2026 01:35:00 PM
- DSS, Inc. Announces Launch of Proposed Public Offering • GlobeNewswire Inc. • 02/04/2026 01:17:01 AM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 01/14/2026 09:30:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:25:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 08:48:41 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 10/21/2025 06:04:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/20/2025 01:47:13 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/03/2025 01:50:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2025 01:43:10 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 08:17:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2025 08:13:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 08:53:38 PM
- DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger • GlobeNewswire Inc. • 06/24/2025 12:30:00 PM
- DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth • GlobeNewswire Inc. • 05/22/2025 12:31:00 PM
